Sirolimus Solution
Product Images NDC 69238-1594

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Sirolimus (NDC 69238-1594). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amneal Pharmaceuticals Ny Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Sirolimus Oral Solution 1)

Chemical structure of sirolimus, depicting its molecular framework with rings, bonds, and functional groups as shown in the image.*

FDA Label Image

Bottle Label (Sirolimus Oral Solution 10)

Sirolimus Oral Solution 1 mg/mL label from Amneal Pharmaceuticals NY LLC. The 60 mL bottle label includes storage instructions to refrigerate at 2° to 8°C and use contents within one month after opening. It states the solution contains 1 mg sirolimus per mL, with ethanol and other excipients, for oral use only. The label also displays the NDC 69238-1594-6 and a barcode.*

FDA Label Image

Inner Carton (Sirolimus Oral Solution 11)

Carton label for Sirolimus Oral Solution 1 mg/mL distributed by Amneal Pharmaceuticals LLC. The 60 mL bottle label includes storage instructions to keep refrigerated at 2° to 8° C, protect from light, and use within 1 month after opening. The label also contains a barcode and directions to see prescribing information.*

FDA Label Image

Outer Carton (Sirolimus Oral Solution 12)

Sirolimus Oral Solution 1 mg/mL packaging label for a 60 mL patient kit by Amneal Pharmaceuticals NY LLC. The label displays the product name, strength, dosage form, and contains patient instructions for oral use. It includes storage requirements to refrigerate the solution between 2° to 8°C and a barcode. The packaging also lists kit contents and usage instructions with simple illustrations.*

FDA Label Image

Carton Figure (Sirolimus Oral Solution 2)

An instructional illustration showing components of an oral dosing kit for Sirolimus solution 1 mg/mL, including a medicine bottle (a), a dosing adapter (b), two oral syringes (c), and an open storage box (d).*

FDA Label Image

Figure 1 (Sirolimus Oral Solution 3)

An instructional illustration depicting a hand placing a cap onto a small bottle. The image shows the action of securing the cap, likely related to the handling or usage of an oral solution medication bottle.*

FDA Label Image

Figure 2 (Sirolimus Oral Solution 4)

An instructional illustration showing a hand holding an oral solution bottle with a dropper, with an arrow indicating a downward motion, likely demonstrating how to use or open the bottle.*

FDA Label Image

Figure 3 (Sirolimus Oral Solution 5)

An instructional illustration showing two steps for using a dosing syringe with a medication bottle. The left panel shows a hand pressing the plunger down, and the right panel shows inserting the syringe into the bottle with the plunger being pushed down.*

FDA Label Image

Figure 4 (Sirolimus Oral Solution 6)

An instructional illustration showing a hand pulling upward on an oral dosing syringe inserted into a small bottle. A close-up circle highlights the syringe measurement markings to aid accurate dosing. The image demonstrates proper use of a dosing syringe with a liquid medicine bottle, likely for oral administration.*

FDA Label Image

Figure 5 (Sirolimus Oral Solution 7)

An instructional illustration showing hands drawing liquid from a vial into a syringe. The image depicts the process of preparing an oral solution dose, consistent with the Sirolimus oral solution product.*

FDA Label Image

Figure 6 (Sirolimus Oral Solution 8)

An instructional line drawing showing a hand holding a prefilled syringe inside an open rectangular box. The illustration likely depicts preparation or handling of an oral solution syringe, consistent with the product Sirolimus 1 mg/mL oral solution by Amneal Pharmaceuticals.*

FDA Label Image

Figure 7 (Sirolimus Oral Solution 9)

An instructional illustration showing a syringe positioned above a clear liquid in a transparent cup. A downward arrow indicates the action of inserting or dispensing the syringe into the liquid. This image likely demonstrates the preparation or mixing step for an oral solution.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.